<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70361</article-id><article-id pub-id-type="doi">10.7554/eLife.70361</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>CRMP4-mediated fornix development involves semaphorin-3E signaling pathway</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-241062"><name><surname>Boulan</surname><given-names>Benoît</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6793-5378</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241063"><name><surname>Ravanello</surname><given-names>Charlotte</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241064"><name><surname>Peyrel</surname><given-names>Amandine</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241065"><name><surname>Bosc</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241066"><name><surname>Delphin</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241067"><name><surname>Appaix</surname><given-names>Florence</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-176494"><name><surname>Denarier</surname><given-names>Eric</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4169-397X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58239"><name><surname>Kraut</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-241068"><name><surname>Jacquier-Sarlin</surname><given-names>Muriel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8501-7511</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55862"><name><surname>Fournier</surname><given-names>Alyson</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-176506"><name><surname>Andrieux</surname><given-names>Annie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4022-6405</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-241069"><name><surname>Gory-Fauré</surname><given-names>Sylvie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-128425"><name><surname>Deloulme</surname><given-names>Jean-Christophe</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2234-5865</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Cellular Neurobiology Research Unit</institution>, <institution>Institut de Recherches Cliniques de Montréal</institution>, <addr-line><named-content content-type="city">Montréal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Inserm, U1216, CEA, Grenoble Institut Neurosciences</institution>, <institution>University Grenoble Alpes</institution>, <addr-line><named-content content-type="city">Grenoble</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">Inserm, U1216, CEA, Grenoble Institut Neurosciences</institution>, <institution>Université Grenoble Alpes</institution>, <addr-line><named-content content-type="city">Grenoble</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">Department of Neurology and Neurosurgery, Montréal Neurological Institute</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montréal</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-16050"><name><surname>Tissir</surname><given-names>Fadel</given-names></name><role>Reviewing editor</role><aff><institution>Université Catholique de Louvain</institution>, <country>Belgium</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>sylvie.gory-faure@univ-grenoble-alpes.fr</email> (SG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>Jean-Christophe.deloulme@univ-grenoble-alpes.fr</email> (JD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>12</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e70361</elocation-id><history><date date-type="received"><day>14</day><month>05</month><year>2021</year></date><date date-type="accepted"><day>02</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Boulan et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Boulan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70361-v2.pdf"/><abstract><p>Neurodevelopmental axonal pathfinding plays a central role in correct brain wiring and subsequent cognitive abilities. Within the growth cone, various intracellular effectors transduce axonal guidance signals by remodeling the cytoskeleton. Semaphorin-3E (Sema3E) is a guidance cue implicated in development of the fornix, a neuronal tract connecting the hippocampus to the hypothalamus. Microtubule-Associated Protein 6 (MAP6) has been shown to be involved in the Sema3E growth-promoting signaling pathway. In this study, we identified the Collapsin Response Mediator Protein 4 (CRMP4) as a MAP6 partner and a crucial effector in Sema3E growth-promoting activity. CRMP4-KO mice displayed abnormal fornix development reminiscent of that observed in Sema3E-KO mice. CRMP4 was shown to interact with the Sema3E tripartite receptor complex within Detergent-<italic>Resistant</italic> Membrane (DRM) domains, and DRM domain integrity was required to transduce Sema3E signaling through the Akt/GSK3 pathway. Finally, we showed that the cytoskeleton-binding domain of CRMP4 is required for Sema3E's growth-promoting activity, suggesting that CRMP4 plays a role at the interface between Sema3E receptors, located in DRM domains, and the cytoskeleton network. As the fornix is affected in many psychiatric diseases, such as schizophrenia, our results provide new insights to better understand the neurodevelopmental components of these diseases.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>2010- Blanc-120201 CBioS</award-id><principal-award-recipient><name><surname>Bosc</surname><given-names>Christophe</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>2017-CE11-0026 MAMAs</award-id><principal-award-recipient><name><surname>Andrieux</surname><given-names>Annie</given-names></name></principal-award-recipient></award-group><funding-statement>The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: The study protocol was approved by the local animal welfare committee (Comité Local GIN, C2EA-04 - APAFIS number 8303-2016060110523424) and complied with EU guidelines (directive 2010/63/EU). Every precaution was taken to minimize the number of animals used and stress to animals during experiments.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for  Figure 2, Figure 4, Figure 5, Figure 6 , Figure 7, Figure 8,  Figure 9, Figure 10 and supplementary File 1</p></sec><supplementary-material><ext-link xlink:href="elife-70361-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>